SmofKabiven Central emulsion for infusion

Licence PA2059/058/002 · Marketed

Licence holder: Fresenius Kabi Deutschland GmbH (all products →)
Active substances: Soya bean oil, refined, Medium chain triglycerides, Refined soyabean oil, Fish oil, rich in omega-3 acids, L-alanine, L-arginine, Glycine (aminoacetic acid), L-histidine, L-isoleucine, L-leucine, L-lysine, L-methionine, L-phenylalanine, L-proline, L-serine, Taurine, L-threonine, L-tryptophan, L-tyrosine, L-valine, Calcium chloride, Sodium glycerophosphate, Magnesium sulfate, Potassium chloride, Sodium acetate, Zinc sulfate, Glucose
Dosage form: Emulsion for infusion
Route of administration: Intravenous use
ATC codes: B05BA, B05BA10
First authorised: 27/11/2009
Prescription status: Product subject to prescription which may not be renewed (A)
Supply: Supply through pharmacies only
Legal basis: Well-established use application (Article 10a of Directive No 2001/83/EC)

Data: Health Products Regulatory Authority (HPRA) open dataset, licensed CC BY 4.0, published 04 Jul 2026. This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.